ArticleFrontiers in neurology2024

Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ study.

Thomas O Crawford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.